A detailed history of Shell Asset Management CO transactions in Vericel Corp stock. As of the latest transaction made, Shell Asset Management CO holds 1,759 shares of VCEL stock, worth $99,717. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,759
Previous 1,861 5.48%
Holding current value
$99,717
Previous $85,000 12.94%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$42.25 - $53.56 $4,309 - $5,463
-102 Reduced 5.48%
1,759 $74,000
Q1 2024

Jul 31, 2024

SELL
$32.52 - $52.33 $3,837 - $6,174
-118 Reduced 5.96%
1,861 $85,000
Q1 2024

May 14, 2024

SELL
$32.52 - $52.33 $2,991 - $4,814
-92 Reduced 4.44%
1,979 $103,000
Q4 2023

Feb 14, 2024

BUY
$30.85 - $37.09 $63,890 - $76,813
2,071 New
2,071 $74,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.